Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sudha Korwar"'
Autor:
Benjamin L. Morris, Dipankar Bandyopadhyay, Zaid Nawaz, Sudha Korwar, Priyadarshan K Damle, Sahib J. Singh, Francisco Zarate-Perez, Carlos Escalante, Michael J Dennis, Xiaoyan Deng, M. Michael Dcona, Keith C Ellis, William E. Royer, Steven R. Grossman
Publikováno v:
Mol Pharmacol
C-terminal binding proteins (CtBP1/2) are oncogenic transcriptional coregulators and dehydrogenases often overexpressed in multiple solid tumors, including breast, colon, and ovarian cancer, and associated with poor survival. CtBPs act by repressing
Autor:
Sudha Korwar, Thomas D. Roper, Caleb J. Kong, B. Frank Gupton, Saeed Ahmad, Swara Fadnis, Nakul Telang, Somi Amir, Bimbisar Desai, Perrer N. Tosso
Publikováno v:
European Journal of Organic Chemistry. 2017:6495-6498
The application of continuous methods in the synthesis of active pharmaceutical ingredients continues to receive significant attention in the academic as well as the industrial research communities. One of the major advantages of continuous methods i
Autor:
Brendan J. Hilbert, Robert A. Coover, William E. Royer, Tyler W. Doughty, Glen E. Kellogg, Sudha Korwar, Keith C. Ellis, Ian M. Love, Benjamin L. Morris, Steven R. Grossman, Hardik I. Parikh
Publikováno v:
Bioorganic & Medicinal Chemistry. 24:2707-2715
C-terminal Binding Protein (CtBP) is a transcriptional co-regulator that downregulates the expression of many tumor-suppressor genes. Utilizing a crystal structure of CtBP with its substrate 4-methylthio-2-oxobutyric acid (MTOB) and NAD+ as a guide,
Autor:
Kendra W. Brinkley, Stanley E. Gilliland, Sudha Korwar, Michael Burkholder, Keith C. Ellis, B. Frank Gupton
Publikováno v:
Chemical communications (Cambridge, England). 53(52)
Chelation-directed C–H activation/C–C bond forming reactions utilizing homogeneous palladium(II) and the Pd(II)/Pd(IV) catalytic cycle have been previously reported. Here we report the first use of a solid-supported Pd(II) catalyst [Pd(II) nanopa
Autor:
Robert A. Coover, Charles E. Lyons, Sudha Korwar, Nicole M. Luzi, Darrell L. Peterson, Keith C. Ellis, Maria E. Casile
Publikováno v:
Organicbiomolecular chemistry. 14(20)
The design and development of irreversible kinase inhibitors is an expanding frontier of kinase drug discovery. The current approach to develop these inhibitors utilizes ATP-competitive inhibitor scaffolds to target non-catalytic cysteines in the kin
Publikováno v:
ChemInform. 46
The title catalyst efficiently promotes C—H activation reactions to allow the transformation of C—H to C—O, C—Cl, and C—Br bonds.
Publikováno v:
Organic letters. 17(7)
N-Chelation-directed C–H activation reactions that utilize the Pd(II)/Pd(IV) catalytic cycle have been previously reported. To date, these reactions employ only homogeneous palladium catalysts. The first use of a solid-supported Pd(II) catalyst [Pd
Preparation and evaluation of deconstruction analogues of 7-deoxykalafungin as AKT kinase inhibitors
Publikováno v:
Bioorganicmedicinal chemistry letters. 24(1)
The pyranonaphthoquinone (PNQ) lactone natural products, including 7-deoxykalafungin, have been reported to be potent and selective covalent inhibitors of AKT kinase. In this work we seek to identify structural features of the natural product scaffol
Autor:
Evan T. Sumner, Steven R. Grossman, Benjamin L. Morris, Brendan J. Hilbert, Keith C. Ellis, M. Michael Dcona, William E. Royer, Sudha Korwar
Publikováno v:
Cancer Research. 76:2003-2003
C-terminal binding proteins 1 and 2 (CtBP) are transcriptional coregulators whose overexpression has been linked to poor prognosis and/or chemoresistance in most common solid tumor types. CtBP exerts oncogenic activities through modulation of gene ex